Islet Cell Tumor
17
1
1
9
Key Insights
Highlights
Success Rate
64% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
29.4%
5 terminated out of 17 trials
64.3%
-22.2% vs benchmark
0%
0 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases